Search for a command to run...
Transpact Enterprises Ltd. is significantly underperforming in key financial metrics compared to its peers in the Medical Equipment sector. The company shows no revenue or earnings growth, lacks profitability, and has an extremely high P/E ratio, indicating it is overvalued. In contrast, Poly Medicure Ltd. stands out as a strong performer with robust growth, solid profitability, and attractive valuation metrics.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Transpact Enterprises Ltd. | ₹178.60 | ₹6.91Cr | 767.51 | - | - |
POLYMED | ₹2,072.30 | ₹20,997.79Cr | 63.37 | 20.37% | 0.06 |
LAXMIDENTL | ₹340.30 | ₹1,870.36Cr | 100.52 | 21.79% | 0.99 |
Prevest Denpro Ltd. | ₹569.55 | ₹683.63Cr | 37.56 | 25.24% | - |
Hemant Surgical Industries Ltd. | ₹297.80 | ₹310.90Cr | 38.24 | - | - |
NURECA | ₹241.55 | ₹241.55Cr | -184.25 | -1.06% | 0.00 |
Raaj Medisafe India Ltd. | ₹84.59 | ₹111.77Cr | 18.23 | - | - |